Skip to content
WealthTicker

Gland Pharma Limited

Held by 145 mutual fund schemes, ₹8,681Cr between them.

The largest single position is HDFC Mid Cap Fund (HDFC), which holds 1.6% of its portfolio in Gland Pharma Limited — ₹1,556Cr, or 17.9% of all the mutual fund money in this stock.

The five largest holders account for 40% of it, across 145 schemes in total.

16 of the 60 largest holdings sit in sectoral/ thematic funds, the most of any category here.

Schemes holding
145
MF money
₹8,681Cr
Largest weight
6.0%
P/E
43.7

Funds holding Gland Pharma Limited

145

Largest rupee position first, top 60 shown. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.

FundCategoryWeightPositionFund size
HDFC Mid Cap FundMid Cap Fund1.62%₹1,556Cr₹96,040Cr
Nippon India Growth Mid Cap FundMid Cap Fund1.55%₹719.90Cr₹46,445Cr
Nippon India Small Cap FundSmall Cap Fund0.64%₹468.22Cr₹73,159Cr
HDFC Large & Mid Cap FundLarge & Mid Cap Fund1.33%₹376.90Cr₹28,339Cr
Nippon India Multi Cap FundMulti Cap Fund0.61%₹321.16Cr₹52,649Cr
Canara Robeco Small Cap FundSmall Cap Fund2.39%₹317.64Cr₹13,291Cr
Nippon India ELSS Tax Saver FundELSS2.16%₹316.70Cr₹14,662Cr
DSP Small Cap FundSmall Cap Fund1.75%₹316.53Cr₹18,087Cr
Mirae Asset Midcap FundMid Cap Fund1.67%₹310.58Cr₹18,571Cr
SBI Contra FundContra Fund0.67%₹307.86Cr₹45,949Cr
Axis Small Cap FundSmall Cap Fund0.87%₹239.56Cr₹27,535Cr
Mirae Asset ELSS Tax Saver FundELSS0.94%₹237.02Cr₹25,328Cr
UTI - Flexi Cap Fund.Flexi Cap Fund1.05%₹234.44Cr₹22,328Cr
Nippon India Pharma FundSectoral/ Thematic2.44%₹207.72Cr₹8,513Cr
Sundaram Mid Cap FundMid Cap Fund1.63%₹206.58Cr₹12,665Cr
Mirae Asset Large Cap FundLarge Cap Fund0.52%₹198.94Cr₹38,017Cr
DSP Healthcare FundSectoral/ Thematic5.98%₹192.42Cr₹3,218Cr
HDFC Multi Cap FundMulti Cap Fund0.72%₹140.77Cr₹19,551Cr
HDFC Manufacturing FundSectoral/ Thematic1.37%₹140.31Cr₹10,241Cr
UTI - Mid Cap FundMid Cap Fund1.11%₹130.28Cr₹11,737Cr
SBI Healthcare Opportunities FundSectoral/ Thematic2.99%₹129.14Cr₹4,319Cr
Mirae Asset Multicap FundMulti Cap Fund2.28%₹113.77Cr₹4,994Cr
Aditya Birla Sun Life MNC FundSectoral/ Thematic3.11%₹101.77Cr₹3,271Cr
UTI - MNC FundSectoral/ Thematic3.83%₹101.53Cr₹2,651Cr
SBI Conservative Hybrid FundConservative Hybrid Fund0.87%₹84.58Cr₹9,722Cr
Axis Multicap FundMulti Cap Fund0.81%₹79.18Cr₹9,775Cr
Mirae Asset Small Cap FundSmall Cap Fund1.77%₹75.16Cr₹4,246Cr
Mirae Asset Healthcare FundSectoral/ Thematic2.44%₹73.50Cr₹3,017Cr
Aditya Birla Sun Life Small Cap FundSmall Cap Fund1.21%₹64.08Cr₹5,300Cr
WhiteOak Capital Mid Cap FundMid Cap Fund0.89%₹49.07Cr₹5,514Cr
UTI - Healthcare FundSectoral/ Thematic3.70%₹43.71Cr₹1,181Cr
Axis India Manufacturing FundSectoral/ Thematic0.83%₹43.39Cr₹5,227Cr
Sundaram Multi Cap FundMulti Cap Fund1.62%₹42.97Cr₹2,658Cr
Nippon India Retirement Fund- Wealth Creation SchemeRetirement Fund1.38%₹41.91Cr₹3,037Cr
HSBC Multi Asset Allocation FundMulti Asset Allocation1.29%₹37.32Cr₹2,893Cr
WhiteOak Capital Flexi Cap FundFlexi Cap Fund0.43%₹34.48Cr₹8,018Cr
Canara Robeco Manufacturing FundSectoral/ Thematic2.13%₹34.29Cr₹1,610Cr
ICICI Prudential MNC FundSectoral/ Thematic1.96%₹33.50Cr₹1,707Cr
Nippon India Nifty Pharma ETFOther ETFs2.27%₹33.10Cr₹1,458Cr
Nippon India Nifty Smallcap 250 Index FundIndex Funds1.04%₹31.72Cr₹3,050Cr
Canara Robeco Multi Cap FundMulti Cap Fund0.58%₹30.43Cr₹5,247Cr
Axis Midcap FundMid Cap Fund0.09%₹29.21Cr₹32,454Cr
Mirae Asset Nifty Smallcap 250 Momentum Quality 100 ETFEquity ETF2.88%₹26.80Cr₹929.33Cr
HDFC NIFTY Smallcap 250 ETFOther ETFs1.04%₹25.30Cr₹2,433Cr
HDFC Pharma and Healthcare FundSectoral/ Thematic1.09%₹24.88Cr₹2,282Cr
Aditya Birla Sun Life Pharma and Healthcare FundSectoral/ Thematic2.63%₹24.20Cr₹920.03Cr
Sundaram Small Cap FundSmall Cap Fund0.69%₹23.75Cr₹3,453Cr
UTI - Unit Linked InsuranceDynamic Asset Allocation or Balanced Advantage0.46%₹22.74Cr₹4,943Cr
HDFC Equity Savings FundEquity Savings0.35%₹19.89Cr₹5,682Cr
Axis Nifty Smallcap 50 Index FundIndex Funds2.79%₹17.33Cr₹621.19Cr
Kotak Healthcare FundSectoral/ Thematic3.04%₹16.31Cr₹536.45Cr
SBI Nifty Smallcap 250 Index FundIndex Funds1.04%₹16.03Cr₹1,541Cr
HDFC Dividend Yield FundDividend Yield Fund0.27%₹15.21Cr₹5,632Cr
WhiteOak Capital Multi Cap FundMulti Cap Fund0.42%₹14.76Cr₹3,513Cr
Motilal Oswal Nifty Smallcap 250 Index FundIndex Funds1.04%₹11.66Cr₹1,121Cr
HDFC MNC FundSectoral/ Thematic2.22%₹11.66Cr₹525.29Cr
Axis Value FundValue Fund0.73%₹11.33Cr₹1,552Cr
Bandhan Healthcare FundSectoral/ Thematic3.05%₹9.19Cr₹301.31Cr
Mahindra Manulife Multi Asset Allocation FundMulti Asset Allocation0.80%₹8.87Cr₹1,109Cr
Aditya Birla Sun Life Nifty Smallcap 50 Index FundIndex Funds2.79%₹8.34Cr₹299.55Cr

Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 125 of the 145 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.

Frequently asked questions

Which mutual fund holds the most Gland Pharma Limited?

By rupee value, HDFC Mid Cap Fund from HDFC — ₹1,556Cr, at 1.6% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.

Which fund has the highest weight in Gland Pharma Limited?

DSP Healthcare Fund carries the largest weight at 6.0% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.

How many mutual funds hold Gland Pharma Limited?

145 schemes, holding ₹8,681Cr between them across the 125 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.

Does a fund holding Gland Pharma Limited make it a good investment?

No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.